Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/34195
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Peynirci, Hande | - |
dc.contributor.author | Taşkıran, Bengür | - |
dc.date.accessioned | 2023-10-04T08:12:54Z | - |
dc.date.available | 2023-10-04T08:12:54Z | - |
dc.date.issued | 2018-06 | - |
dc.identifier.citation | Peynirci, H. vd. (2018). ''Is parenteral levothyroxine therapy safe in intractable hypothyroidism?''. Journal of the National Medical Association, 110(3), 245-249. | en_US |
dc.identifier.issn | 0027-9684 | - |
dc.identifier.issn | 1943-4693 | - |
dc.identifier.uri | https://doi.org/10.1016/j.jnma.2017.05.007 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/abs/pii/S0027968417300287 | - |
dc.identifier.uri | http://hdl.handle.net/11452/34195 | - |
dc.description.abstract | Case: A 32-year old woman was admitted to the hospital due to intractable hypothyroidism refractory to high dose of oral L-thyroxine therapy. She underwent total thyroidectomy and radioactive iodine therapy due to papillary thyroid cancer. After excluding poor adherence to therapy and malabsorption, levothyroxine absorption test was performed. No response was detected. Transient neurologic symptoms developed during the test. She developed 3 attacks consisting of neurologic symptoms during high dose administration. The patient was considered a case of isolated L-thyroxine malabsorption. She became euthyroid after intramuscular twice weekly L-thyroxine therapy. Discussion: There are a few case reports regarding isolated L-thyroxine. We report successful long term results of twice weekly administered intramuscular L-thyroxine therapy. We also draw attention to neurologic side effects of high dose L-thyroxine therapy. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Natl Med Assoc | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | General & internal medicine | en_US |
dc.subject | Hypothyroidism | en_US |
dc.subject | Levothyroxine | en_US |
dc.subject | Malabsorption | en_US |
dc.subject | Neurologic manifestations | en_US |
dc.subject | Thyroxine absorption | en_US |
dc.subject | Pseudomalabsorption | en_US |
dc.subject | Malabsorption | en_US |
dc.subject | Replacement | en_US |
dc.subject | Patient | en_US |
dc.subject | Disease | en_US |
dc.subject.mesh | Administration, oral | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hypothyroidism | en_US |
dc.subject.mesh | Injections, intramuscular | en_US |
dc.subject.mesh | Intestinal absorption | en_US |
dc.subject.mesh | Malabsorption syndromes | en_US |
dc.subject.mesh | Thyroid cancer, papillary | en_US |
dc.subject.mesh | Thyroid neoplasms | en_US |
dc.subject.mesh | Thyroidectomy | en_US |
dc.subject.mesh | Thyroxine | en_US |
dc.subject.mesh | Treatment outcome | en_US |
dc.title | Is parenteral levothyroxine therapy safe in intractable hypothyroidism? | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000432909100008 | tr_TR |
dc.identifier.scopus | 2-s2.0-85020916109 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Endokrinoloji ve Metabolik Bozukluklar Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 245 | tr_TR |
dc.identifier.endpage | 249 | tr_TR |
dc.identifier.volume | 110 | tr_TR |
dc.identifier.issue | 3 | tr_TR |
dc.relation.journal | Journal of the National Medical Association | en_US |
dc.contributor.buuauthor | Ertürk, Erdinç | - |
dc.contributor.buuauthor | Şişman, Pınar | - |
dc.contributor.buuauthor | Ersoy, Canan | - |
dc.contributor.researcherid | AAJ-6536-2021 | tr_TR |
dc.contributor.researcherid | AAH-8861-2021 | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 29778126 | tr_TR |
dc.subject.wos | Medicine, general & internal | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 7005488796 | tr_TR |
dc.contributor.scopusid | 57190169474 | tr_TR |
dc.contributor.scopusid | 6701485882 | tr_TR |
dc.subject.scopus | Levothyroxine Sodium; Hypothyroidism; Thyrotropin | en_US |
dc.subject.emtree | Acetylsalicylic acid | en_US |
dc.subject.emtree | Levothyroxine | en_US |
dc.subject.emtree | Liothyronine | en_US |
dc.subject.emtree | Thyrotropin | en_US |
dc.subject.emtree | Thyroxine | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Aphasia | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Blood pressure | en_US |
dc.subject.emtree | Body mass | en_US |
dc.subject.emtree | Body temperature | en_US |
dc.subject.emtree | Body weight gain | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Drug megadose | en_US |
dc.subject.emtree | Drug safety | en_US |
dc.subject.emtree | Dry skin | en_US |
dc.subject.emtree | Fatigue | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Free thyroxine index | en_US |
dc.subject.emtree | Heart rate | en_US |
dc.subject.emtree | Hemiparesis | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Hypertension | en_US |
dc.subject.emtree | Hypothyroidism | en_US |
dc.subject.emtree | Menstruation | en_US |
dc.subject.emtree | Physical examination | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Side effect | en_US |
dc.subject.emtree | Thyroid function test | en_US |
dc.subject.emtree | Thyrotropin blood level | en_US |
dc.subject.emtree | Transient ischemic attack | en_US |
dc.subject.emtree | Treatment response | en_US |
dc.subject.emtree | Visual impairment | en_US |
dc.subject.emtree | Hypothyroidism | en_US |
dc.subject.emtree | Intestine absorption | en_US |
dc.subject.emtree | Intramuscular drug administration | en_US |
dc.subject.emtree | Malabsorption | en_US |
dc.subject.emtree | Metabolism | en_US |
dc.subject.emtree | Oral drug administration | en_US |
dc.subject.emtree | Pathology | en_US |
dc.subject.emtree | Pathophysiology | en_US |
dc.subject.emtree | Procedures | en_US |
dc.subject.emtree | Thyroid tumor | en_US |
dc.subject.emtree | Thyroidectomy | en_US |
dc.subject.emtree | Treatment outcome | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.